Association between Early Immune-Related Adverse Events and Survival in Patients Treated with PD-1/PD-L1 Inhibitors

Association between Early Immune-Related Adverse Events and Survival in Patients Treated with PD-1/PD-L1 Inhibitors

Background: Immune-related adverse events (irAEs) are side effects that reflect the activation of patients’ immune systems after treatment with immune checkpoint inhibitors (ICIs). However, there is no meta-analysis on the effect of early irAEs on patient survival. Thus, we assessed the association...

Full description

Bibliographic Details
Main Authors: You-Cheng Zhang, Tian-Chen Zhu, Run-Cong Nie, Liang-He Lu, Zhi-Cheng Xiang, Dan Xie, Rong-Zhen Luo, Mu-Yan Cai
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Journal of Clinical Medicine
Subjects:
immune-related adverse events
efficacy
immune checkpoint inhibitors
tumor
meta-analysis
Online Access:https://www.mdpi.com/2077-0383/12/3/736

Internet

https://www.mdpi.com/2077-0383/12/3/736

Similar Items